HNN3.0

Project cooperationUpdated on 12 January 2026

Advanced 3D-Printed Biomaterial and Bioink Platforms for Disease-Specific cellular models

BioProducts R&D Manager | Regulatory Compliance Officer at COLFEED4Print

Madrid, Spain

About

COLFEED seeks partners to co-develop next-generation organoid platforms using functionalized, easy-to-print biomaterial feedstocks and bioinks for New Approach Methodologies (NAMs) in biomedical research and regulatory drug testing.

COLFEED is a biomaterials manufacturer specializing in 3D printing feedstocks for FDM, with:

  • Patented technology for functionalized, easy-to-print biomaterials

  • Strong experience translating materials into clinical and hospital environments

  • Active collaborations with hospital-based 3D printing units for point-of-care manufacturing

  • Expertise in scalability, reproducibility and manufacturability, key for regulatory acceptance

Within the consortium, COLFEED can lead or contribute to:

  • Development of printing-grade biomaterials and bioinks

  • Design of organoid-supportive scaffolds and matrices

  • Integration of manufacturing workflows compliant with regulatory expectations

  • Technology transfer toward clinical and industrial environments

Partners may contribute to organoid biology, analytical validation, disease modeling, clinical relevance or regulatory alignment.

Topic

  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing

Similar opportunities